Our Services
From your 1st IND to commercial readiness, we provide the technical, regulatory and compliance expertise that clinical stage biotech companies need to move forward with confidence.
We work alongside your team — not above it. Every engagement is scoped to your stage, your resources, and your regulatory timeline.
01
Build a compliance program that scales with your pipeline.
We assess your current state against FDA, EMA, and ICH GxP requirements and design a compliance roadmap tailored to your development stage. Whether you're establishing your first GMP program or remediating gaps ahead of an inspection, we bring the rigor of large pharma with the agility early-stage companies require.
Capabilities
02
Scalable QMS architecture built for growth.
A well-designed Quality Management System is the backbone of every successful regulatory submission. We design, implement, and optimize QMS frameworks — from document control and CAPA to deviation management and change control — that meet current regulatory expectations and scale as your organization grows.
Capabilities
03
Audit-ready documentation your team will actually use.
Standard Operating Procedures are only valuable if they're accurate, compliant, and followed. Our team authors, reviews, and revises SOPs across all functional areas — manufacturing, quality control, clinical operations, and more — ensuring they meet FDA and ICH requirements while remaining practical for your staff.
Capabilities
04
Technical writing and CMC support for global submissions.
We translate your science into regulatory-ready documentation. Our team provides technical writing and CMC support for IND, NDA, BLA, and MAA submissions — helping you present your data clearly, completely, and in the format regulators expect.
Capabilities
05
Validation strategy aligned with current regulatory expectations.
Process validation is a critical milestone on the path to commercial manufacturing. We develop validation strategies, author protocols, and support execution for manufacturing processes, cleaning validation, and analytical method validation — all aligned with FDA Process Validation Guidance and ICH Q8/Q9/Q10.
Capabilities
06
Prepare your organization before regulators arrive.
An FDA or EMA inspection is not the time to discover gaps. We conduct pre-inspection assessments and mock audits that mirror real regulatory scrutiny — identifying vulnerabilities, prioritizing remediation, and coaching your team so they're confident and prepared when the day comes.
Capabilities
Most of our engagements begin with a no-obligation discovery call. We'll assess your current state and recommend the right scope for your stage.
No retainer required. Start with a discovery call.
Schedule a Discovery Call